Beth Boland, partner, national chair of Foley’s Securities Enforcement Litigation Practice and vice chair of the Litigation Department, was named to the Top 50: 2015 Women Massachusetts Super Lawyers. The list recognizes the top female Super Lawyers who received the highest point totals in the Massachusetts nomination, research and blue ribbon review process.
Boland regularly represents corporations in connection with insider trading issues, Ponzi schemes, accounting fraud, corporate control issues and derivative actions. She has experience defending some of the nation’s largest financial institutions in connection with class action litigation and multi-agency enforcement actions. In addition, Boland sits on the board of the New England Chapter of the National Association of Corporate Directors.
Boland regularly represents corporations in connection with insider trading issues, Ponzi schemes, accounting fraud, corporate control issues and derivative actions. She has experience defending some of the nation’s largest financial institutions in connection with class action litigation and multi-agency enforcement actions. In addition, Boland sits on the board of the New England Chapter of the National Association of Corporate Directors.
People
Related News
July 8, 2025
Press Releases
Foley Expands Tax Capabilities with Addition of Partner David Morris in Salt Lake City
Foley & Lardner LLP announced today that David Morris has joined the firm’s Salt Lake City office as a partner in its Taxation Practice Group.
June 5, 2025
Press Releases
Foley Secures Top Rankings in Chambers USA 2025
Foley & Lardner LLP is proud to once again be recognized by Chambers & Partners as one of the leading law firms in the country in the 2025 edition of Chambers USA: America’s Leading Lawyers for Business.
June 2, 2025
Press Releases
Foley Opens Nashville Office with Addition of Three Corporate Partners
Foley & Lardner LLP announced today the opening of its newest office in Nashville, Tenn., with the addition of three corporate partners to support the firm’s growing Health Care & Life Sciences and Manufacturing Sectors.